Hanseatic Management Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Hanseatic Management Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-134	Closed	-$15K	–	181
2021 Q3	$15K	Hold	134	–	–	0.03%	107
2021 Q2	$13K	Buy	134 +1	+0.8%	+$92	0.02%	106
2021 Q1	$12K	Buy	133 +1	+0.8%	+$84	0.02%	111
2020 Q4	$10K	Hold	132	–	–	0.02%	119
2020 Q3	$10K	Buy	+132	New	+$9.08K	0.02%	145
2015 Q4	–	Sell	-1,570	Closed	-$31K	–	427
2015 Q3	$31K	Sell	1,570 -84	-5%	-$2.65K	0.01%	229
2015 Q2	$57K	Buy	1,654 +1,565	+1,758%	+$47.8K	0.03%	173
2015 Q1	$2K	Buy	+89	New	+$1.63K	﹤0.01%	284

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hanseatic Management Services's HZNP Position: Q4 2021 in Review

Hanseatic Management Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2021, closing a stake of 134 shares — an estimated $15K sold.

Hanseatic Management Services first reported a position in HZNP in Q1 2015 and held it in 8 quarters. The position peaked at $57K in Q2 2015. 610 funds tracked by Wall St. Rank hold HZNP as of Q4 2021.

Hanseatic Management Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2021 after selling out during the quarter.
Hanseatic Management Services sold 134 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2021, an estimated $15K.
Hanseatic Management Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 8 quarters.
Hanseatic Management Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $57K in Q2 2015.
610 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2021.

Based on Hanseatic Management Services's 13F filing for Q4 2021, filed 9 Feb 2022.